2023 net revenues increased 4.5% to $1.05 billion, compared to 20222023 net income of $51 million or $0.18 per diluted share2023 Adjusted EBITDA increased 4.3% to $528 million2023 Adjusted EPS .
01.11.2023 - Q3 2023 net revenues of $263 million increased 6%, compared to Q3 2022Q3 2023 net loss of $14 million or $0.05 per diluted share, compared to net income of $25 million or $0.09 per diluted share in Q3 2022 Q3 2023 Adjusted EBITDA of $134 million .
United Health Products Announces Equity Financing Agreement and Provides Corporate Update streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
NEW YORK, July 6, 2022 /PRNewswire/ As per Zion Market Research study, the global hospital-acquired infection control market was valued at USD 28.99 billion in 2021. The global market is
/PRNewswire/ As per Zion Market Research study, the global hospital-acquired infection control market was valued at USD 28.99 billion in 2021. The global.